These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21350111)

  • 1. Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival.
    Miyamoto T; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Lindholm B; Stenvinkel P
    Clin J Am Soc Nephrol; 2011 May; 6(5):1001-8. PubMed ID: 21350111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.
    Chang YT; Wu HL; Guo HR; Cheng YY; Tseng CC; Wang MC; Lin CY; Sung JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3588-95. PubMed ID: 21444362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
    Manghat P; Fraser WD; Wierzbicki AS; Fogelman I; Goldsmith DJ; Hampson G
    Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremic toxicity and sclerostin in chronic kidney disease patients.
    Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
    Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.
    Fife E; Kostka J; Kroc Ł; Guligowska A; Pigłowska M; Sołtysik B; Kaufman-Szymczyk A; Fabianowska-Majewska K; Kostka T
    BMC Geriatr; 2018 Aug; 18(1):200. PubMed ID: 30165829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease.
    Cigarrán S; Pousa M; Castro MJ; González B; Martínez A; Barril G; Aguilera A; Coronel F; Stenvinkel P; Carrero JJ
    J Ren Nutr; 2013 Sep; 23(5):e89-95. PubMed ID: 23046736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease.
    Hyun YY; Lee KB; Oh KH; Ahn C; Park SK; Chae DW; Yoo TH; Cho KH; Kim YS; Hwang YH;
    Nutrition; 2017 Jan; 33():254-260. PubMed ID: 27692989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
    Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
    Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.
    Hyun YY; Lee KB; Han SH; Choi KH; Park HC; Oh YK; Park SK; Oh KH; Ahn C;
    Osteoporos Int; 2020 Dec; 31(12):2373-2382. PubMed ID: 32642852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary Protein Intake, Protein Energy Wasting, and the Progression of Chronic Kidney Disease: Analysis from the KNOW-CKD Study.
    Lee SW; Kim YS; Kim YH; Chung W; Park SK; Choi KH; Ahn C; Oh KH
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
    Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease.
    Ozkok A; Elcioglu OC; Cukadar T; Bakan A; Sasak G; Atilgan KG; Alisir S; Kanbay M; Covic A; Odabas AR
    Int Urol Nephrol; 2013 Apr; 45(2):477-84. PubMed ID: 22907629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.
    Jovanovich A; Isakova T; Block G; Stubbs J; Smits G; Chonchol M; Miyazaki M
    Am J Kidney Dis; 2018 Jan; 71(1):27-34. PubMed ID: 28801122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength.
    Chen Z; Nilsson E; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi AR; Chen J
    J Ren Nutr; 2023 Mar; 33(2):298-306. PubMed ID: 35792256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.